Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma

Area of Science:

• Oncology
• Immunology
• Pediatric Neuro-oncology

Background:

• Medulloblastoma (MB) is a common pediatric brain tumor with distinct molecular subgroups.
• The sonic hedgehog (SHH) subgroup shows high infiltration of tumor-associated microglia/macrophages (TAMs) and resistance to anti-SHH therapies.
• The role of TAMs in SHH-MB pathogenesis and drug resistance is not fully understood.

Purpose of the Study:

• To investigate the mechanism of TAM activation and polarization in SHH-MB.
• To identify potential immunotherapeutic targets to overcome drug resistance in SHH-MB.
• To explore the therapeutic potential of targeting TAMs in combination with existing therapies.

Main Methods:

• Analysis of immune microenvironment (IME) profiles in MB subgroups using NanoString PanCancer IO360 panel.
• Distinguishing M1/M2-like TAMs in human MB tumors and transgenic mouse models.
• Investigating the role of MB-derived exosomes and exosomal miRNAs in TAM polarization using RNA sequencing and luciferase assays.
• Evaluating the efficacy of a PPARγ antagonist in combination with a SMO inhibitor in vivo.

Main Results:

• TAMs are the predominant immune component in SHH-MB, with M2-like macrophages enriched.
• MB-derived exosomes induce TAM polarization, with down-regulation of let-7i-5p and miR-221-3p promoting M2-like polarization via PPARγ upregulation.
• Inhibition of PPARγ potentiates the antitumor activity of SMO inhibitors in SHH-MB models, potentially by modulating M2-like TAMs.

Conclusions:

• M2-like TAMs contribute to SHH-MB progression and drug resistance.
• Exosomal miRNAs play a crucial role in regulating TAM polarization in SHH-MB.
• Targeting M2-like TAMs, specifically via PPARγ inhibition, represents a promising strategy to enhance therapeutic responses to SMO inhibitors in SHH-MB.